FDA approved drug library - Enzo Life Sciences

BML-2841

Revised 01-Feb-10

FDA approved drug library
PRODUCT LINE	Drug Discovery
PRODUCT CATEGORY	Compound Libraries

Ordering Information

Product Numbers:	Format:	Size:	Unit Price:	Quantity:	Add To Cart
BML-2841-0100	100 µl/well	1 Library
BML-2841-0500	500 µl/well	1 Library

Product Specification

QUANTITY:	100µl or 500µl per well
CONCENTRATION:	DMSO solutions (2 mg/ml)
KIT/SET CONTAINS:	640 compounds, selected to maximize chemical and pharmacological diversity
FORMULATION:
SHIPPING:	SHIPPED ON DRY ICE
LONG TERM STORAGE:	-20°C

Product Description

Screening FDA-approved drugs accelerates drug discovery:

· 100% known bioactivity

· Greatest degree of drug-likeness available

· Known safety & bioavailability

· Accelerates drug optimization

Drug repositioning or repurposing can be an important part of any drug discovery program and has led to several blockbuster drugs (e.g. Viagra and Rogaine). High-content screens, new biomarkers and noninvasive imaging techniques have created new opportunities for pursuing novel indications for approved compounds. Being FDA approved and in use in the clinics, all of the compounds in BIOMOL’s FDA Approved Drug Library have known and well-characterized bioactivities and have undergone extensive safety & bioavailability testing, which could dramatically accelerate your drug discovery program. This set provides one of the richest sources of bioactives and offers the greatest degree of drug-likeness available. Hits from this set will provide a significant head start in any drug optimization program.
Contact compoundlibraries@enzolifesciences.com for a complete list of compounds in the library.

General Information